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Article
Swelling is associated with stiffness and unsatisfactory 
outcomes after ankle surgery.2,5,8,12 Therefore, reduction of 
ankle swelling after foot and ankle surgery is desired. 
Compressive stockings (CS) therapy is purported to prevent 
deep vein thrombosis and postthrombotic syndrome in case 
of prolonged immobilization.4,10,11 In addition, the use of 
CS appears to reduce ankle swelling and correlates with 
superior ankle function, reduced pain, and improved quality-
of-life scores after ankle fractures and open ankle sur-
gery.2,13,15 But for CS to be efficient, patients should wear 
them as advised. We cannot speculate or study the efficacy 
of a postoperative CS therapy without assessing patients’ 
wearing compliance. It is known that patients’ compliance 
analysis by a questionnaire is not reliable.1,7,9,14,16
The primary aim of this randomized controlled study 
was to evaluate functional outcomes and quality of life of 
patients undergoing ankle and hindfoot surgery with vs 
without the use of postoperative CS. The secondary objective 
of this clinical study was to evaluate the CS wearing time 
and patients’ compliance by the use of a sensor device, 
which was implanted covertly into the CS. We tested the 
hypothesis of whether wearing CS would translate to 
improved ankle swelling status, reduced pain, better 
American Orthopaedic Foot & Ankle Score (AOFAS) 
score, and better quality of life.
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Abstract
Background: Swelling and pain are common after foot and ankle procedures. We hypothesized that compressive stockings 
(CS) treatment after hindfoot surgery would positively influence patient outcomes.
Methods: We undertook this randomized controlled trial in 87 consecutive patients to analyze the clinical effect of CS 
after hindfoot and ankle surgery and evaluate CS-wearing compliance using sensors that were implanted into CS. Ankle 
swelling, pain status, quality of life (SF-36 score), and the American Orthopaedic Foot & Ankle Score (AOFAS) were set as 
the primary end points. The CS wearing time in hours and percentage were investigated as the secondary end points. All 
participants with CS (group I) were informed about the implanted sensor after the CS were taken off. A subgroup analysis 
of group I was performed to detect differences between patients with high vs low compliance.
Results: At 12 weeks, the results of ankle swelling (mean 234 mm in group I and 232 mm in group II), pain in the 
visual analog scale (1.7 group I vs 1.9 in group II), the SF-36 score (38 points in group I vs 30 points in group II), and the 
AOFAS score (a mean of 76 points in both groups) showed no statistical differences between the 2 groups. The mean 
wearing time was 136 (range, 0-470) hours, which corresponds to a compliance rate of 65%. Sixteen participants had 
high compliance (>80%, >170 hours), and 21 patients had low or noncompliance. The clinical results of patients with high 
wearing compliance were not significantly better compared to the results of patients with low compliance.
Conclusion: CS therapy after ankle and hindfoot surgery was associated with a low wearing compliance and did not 
influence ankle swelling, function, pain, and the quality of life compared to the control group. Furthermore, the clinical 
results of patients with high compliance were not better compared to the results of patients with low or noncompliance 
wearing behavior.
Level of Evidence: Level II, prospective randomized study of lower quality.
Keywords: compressive stockings, sensor-controlled compliance analysis, foot and ankle surgery
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Methods
The study was a single-center, single-blind, prospective ran-
domized study involving patients undergoing hindfoot sur-
gery. The study protocol, participant information sheet and 
consent forms, and patient-reported questionnaires were 
submitted and approved by the local ethical committee of 
Zurich, Switzerland, prior to study initiation. The study pro-
tocol was registered at clinicaltrials.gov as NCT02792907.
The participant population was adult male and female 
patients who were listed for a foot and ankle surgery at the 
University Hospital Balgrist. Our inclusion criteria included 
patients willing to undergo standardized postoperative 
physiotherapy, comply with postoperative instructions, 
willing to be randomized to 1 of 2 groups, and able to 
provide consent by themselves. The patients were informed 
about the intention of the study in advance but were not 
primarily informed about the use of the temperature-capturing 
sensor, which was implanted in the CS so as to assess their 
compliance. A second consent form was obtained after the 
participants were informed about the implanted sensor. This 
information was given retrospectively after the CS treat-
ment was terminated. If the participants denied further 
study participation, the patient was excluded from the study 
and the information from the sensors was deleted. The 
exclusion criteria for the study were patients with a contra-
indication for the use of CS, patients who were treated with 
an external fixator, and patients who could not provide writ-
ten informed consent for participation in the study. Patients 
with postoperative cast treatment were not excluded from 
the study because compressive stockings were wearable 
beneath the split casts. Patients whose prospects for a recov-
ery to independent mobility would be compromised by 
known coexistent, medical problems like cancer or 
advanced rheumatoid arthritis were also excluded from the 
study. All participants were encouraged to remain in the 
study through to 12 weeks postsurgery; nevertheless, par-
ticipants had the right to voluntarily withdraw from the 
study at any time for any reason. All potential participants 
were screened for eligibility by their surgeon or trained 
member of the research department.
The participants were randomized and blindly assigned 
with sealed envelopes into group I, in which all participants 
had to wear CS for 4 weeks, or into group II, which served 
as the control group in which CS therapy was not used. 
Primarily, the patients were subdivided into forefoot, 
midfoot, and hindfoot subdivisions. After 4 patients of the 
forefoot and midfoot group claimed discomfort during 
dressing and undressing the CS over the operated foot, the 
study protocol was changed and only patients with hindfoot 
and ankle surgeries were included because these patients 
had no problems with wearing and undressing the CS. All 
data from the study participants were collected and encoded 
online in the REDCap software system (Vanderbilt 
University Medical Center, Nashville, TN).
From July 2016 to January 2017, a total of 90 patients 
were recruited as participants. Final analysis was performed 
in 76 (41 female and 35 male) patients with a mean age of 
46 (range, 18-79) years. The mean body weight was 80 
(range, 47-130) kg. The 76 patients were randomly assigned 
into the 2 groups, with 37 patients in the CS group and 39 
patients in the control group. The indications of ankle and 
hindfoot surgery are listed in Table 1. There were no statisti-
cal differences between the groups according to age, sex, 
and weight (Figure 1).
Three patients did not meet the inclusion criteria after 
randomization. One participant had a wound-healing 
problem and another patient showed severe swelling of 
the operated foot so that adjustment of the CS was impos-
sible, and both were excluded. Two participants disposed 
the compressive stockings into the garbage and were 
therefore excluded from the study. Two participants of the 
intervention group and 4 participants of the control group 
withdrew. One participant of the intervention group 
denied the readout of the sensor and subsequently 
withdrew (Figure 2).
Intervention
The patients who were randomized into group I (the “stock-
ings group”) received a knee-high class II CS with 23- to 
32-mm Hg pressure (Mediven, Bayreuth, Germany) on the 
operated foot after the stiches were removed 14 days after 
the index surgery. The size of the CS was determined after 
an experienced orthopedic technician measured the inter-
malleolar diameter. The patients were instructed to wear the 
CS for at least 8 hours daily until the 6-week appointment 
postsurgery. A sensor (Orthotimer, Balingen, Germany) was 
implanted into the top of the stocking (Figure 3). The cer-
tificated sensor measured the surrounding temperature with 
an accuracy of 0.01°C every 15 minutes. The sensor has a 
capture threshold of 33°C, which means that if the sur-
rounding temperature was 33°C or more, the sensor cap-
tured this moment as an event. After the 4-week CS 
treatment, the sensor was explanted and the patients were 
informed retrospectively about the sensor. The participants 
signed a second consent form prior to the readout of the sen-
sor. The readout was performed with software from the 
same sensor company (Orthotimer). The wearing time of 
the compressive stockings was evaluated in hours in total 
and in percentage of the declared wearing time. Each sensor 
was tested before the implantation and after the readout to 
rule out any hardware failure. The sensor end test report 
ensured the sensor’s function.
Outcomes
The outcome parameters were set preliminarily. 
Preoperatively and at the regular 6- and 12-week follow-up 
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appointments, the same outcome parameters were obtained. 
Our primary objectives included ankle swelling, pain, qual-
ity of life, and functional scores. The swelling status was 
measured in millimeters at the intermalleolar ankle level. 
The pain status was evaluated by visual analog scale (VAS) 
from 0 (no pain) to 10 (most imaginable pain) points. The 
quality-of-life status was assessed using the Medical 
Outcomes Short Form Questionnaire (SF-36).2 Functional 
outcomes were assessed using the American Orthopaedic 
Foot & Ankle Score (AOFAS).6 Two authors (S.C. and 
R.S.) carried out the measurement of outcome parameters at 
different time points. Our secondary end point was the CS 
Table 1. Demographics of the Intervention vs the Control Group.
Characteristic
Intervention Group  
(Compressive stockings) (n = 37)
Control Group 
(n = 39)
Female/male, No. 18/19 23/16
Age, mean (range), y 42 (18-70) 47 (19-79)
Weight, mean (range), kg. 79 (50-103) 80 (47-130)
Body mass index, mean (range), kg/m2 27 (19-39) 28 (20-45)
Indication for surgery, No.  
 Ankle arthritis 5 3
 Ankle fracture 3 0
 Ankle impingement 4 7
 Ankle instability 3 2
 Achilles tendon rupture 1 5
 Disturbing metal 2 1
 Flatfoot 3 2
 Osteochondral lesion 7 10
 Peroneal tendon rupture 9 9
Figure 1. Boxplots showing no differences in patients’ characteristics.
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wearing time in absolute number (hours) and in relation to 
the declared wearing time (%).
Sample Size Calculation
The group size of the intervention group and the particular 
control group was defined after a power analysis that was 
performed by the Department of Biostatistics at Zurich 
University. Demanding the group power of 80% and a 
significance level of 5%, each of the 6 groups needed to 
have 37 participants to detect a difference of 10 mm in the 
ankle diameter. As only the hindfoot group was included, 
the aspired total number of participants was 74. The 
prospective recruitment stopped after the aspired number 
Figure 2. The flow diagram of study participants.
Grubhofer et al 5
of 74 participants with at least 37 patients in each arm was 
reached.
Randomization
Data collection was consistent with Good Clinical Practices 
guidance. Each patient participating in this study was 
assigned a unique identifier (ie, a study subject identifica-
tion number) and data collected were confidentially 
recorded. All study numbers were allocated either to group 
I or group II. The randomized allocation of the study par-
ticipant’s numbers was performed before the recruitment 
phase started. Recruitment was performed by the REDCap 
software system (Vanderbilt University Medical Center).
Statistical Analysis
The study participants’ demographics were analyzed using 
an analysis of variance according to their age, sex, body 
weight, and indications for surgery. Study data were 
collected and managed using the REDCap electronic data 
capture tool3 (version 6.7.4 © 2015 Vanderbilt University). 
The nonpaired Student t test was used to compare the 
differences between the 2 groups. The differences within 
the same group before and after the index surgery were 
evaluated by using the paired Student t test. P values less 
than .05 were considered significant.
Results
All participants showed an increase of the ankle diameter 
from a mean of 226 (range, 173-280) mm preoperatively to a 
mean of 233 (range, 180-330) mm 6 weeks postoperatively 
and to a mean of 233 (range, 170-310) mm 12 weeks postop-
eratively. Group I had a mean diameter of 224 (range, 185-
270) mm preoperatively, 235 (range, 190-330) mm 6 weeks 
postoperatively, and 234 (range, 190-285) mm 12 weeks 
postoperatively. The control group showed a mean ankle 
diameter of 228 (range, 173-280) mm preoperatively, 231 
(range, 180-290) mm 6 weeks postoperatively, and 232 
(range, 190-310) mm 12 weeks postoperatively. The mean 
pain level rose in all participants with statistical significance 
from 1.2 (range, 0-5) preoperatively to 1.7 (range, 0-7) 12 
weeks postoperatively. Group I showed an increase of pain 
from 1 (range, 0-5) to 1.7 (range, 0-7) VAS points, and group 
II showed an increase of pain from 1.4 (range, 0-5) to 1.9 
(range, 0-7) VAS points. The SF-36 score declined from a 
mean 37 (range, 5-61) points preoperatively to 34 (range, 
10-61) points 12 weeks postoperatively (P = .20). Group I had 
38 (range, 15-61) points preoperatively and 38 (range, 14-59) 
points 12 weeks postoperatively with no decline in quality of 
life, whereas the control group had a mean regression from 35 
(range, 5-59) points to 30 (range, 10-69) points 12 weeks 
postoperatively. The AOFAS score improved in all patients 
from 71 (range, 12-95) preoperatively to 78 (range, 30-100) 
points 12 weeks postoperatively. The intervention group 
improved from 68 (range, 34-92) points preoperatively to 76 
(range, 30-100) points 12 weeks postoperatively. The control 
group improved from 74 (range, 12-95) preoperatively to 76 
(range, 45-100) points 12 weeks postoperatively.
The mean CS wearing time in the declared wearing period (4 
weeks, 8 hours daily = 224 hours) was 136 (range, 0-470) hours, 
which corresponds to a mean wearing compliance rate of 65% 
(range, 0-209%). Sixteen participants of the intervention group 
wore the stockings on average 270 (range, 174-470) hours, 
which is 129% (range, 84-209%) of the declared wearing time. 
The remaining 21 participants wore the stockings an average of 
34 (range, 0-148) hours, or 16% (range, 0-74%) of the declared 
wearing time. All results are summarized in Table 2.
The changes in the preoperative to the 12-week postopera-
tive scores of all primary end points (swelling, pain, quality of 
life, and AOFAS) were not statistically different between the 2 
groups (Figure 4). As the participants from group I showed dif-
ferent CS wearing behavior, a subgroup analysis was per-
formed to compare the results between participants with high 
wearing (n = 16) vs those with low wearing compliance (n = 
21). Patients with a wearing time of 80% or more were allo-
cated to subgroup I (high-compliance group), and patients with 
less than 80% wearing time were in subgroup II (low-compli-
ance group). Ankle swelling increased in subgroup I from a 
mean of 220 (range, 190-260) to 225 (range, 195-270) mm 6 
weeks postoperatively and to a mean of 233 (range, 200-265) 
mm 12 weeks postoperatively. In subgroup II, the diameter 
increased from a mean of 227 (range, 185-270) mm preopera-
tively to a mean of 242 (range, 190-330) mm 6 weeks postop-
eratively and to a mean of 233 (range, 190-285) mm 12 weeks 
postoperatively. The pain level rose in subgroup I from a mean 
of 0.7 (range, 0-2.5) points to a mean of 1.2 (range, 0-5) points 
and in subgroup II from 1.2 (range, 0-5) points to a mean of 2.2 
(range, 0-6) points 12 weeks postoperatively. Quality of life 
improved from preoperative 41 (range, 18-61) to 42 (range, 
17-59) points 12 weeks postoperatively in subgroup I, whereas 
Figure 3. Green temperature capturing sensor in correlation 
to a one cent (€) coin.
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in subgroup II, the mean score declined from 37 (range, 15-56) 
to 34 (range, 14-53) points. The AOFAS scores rose in sub-
group I from 74 (range, 46-90) points preoperatively to 80 
(range, 36-100) points 12 weeks postoperatively and in sub-
group II from 66 (range, 34-92) points preoperatively to 73 
(range, 30-100) points 12 weeks postoperatively. All changes 
between the preoperative and the 12-week postoperative scores 
(swelling, pain, SF-36, and AOFAS) were not statistically dif-
ferent between the 2 groups (Figure 5 and Table 3).
Complications
In 2 participants from the intervention group and 1 from the 
control group, wound-healing problems occurred 3 to 4 
weeks after surgery. In all 3 patients, no further operative 
intervention was needed and the wound healed without any 
signs of an infection at the last follow-up visit.
Discussion
The study demonstrated that the postoperative use of CS 
showed no beneficial effects on patients’ outcome parameters 
and was associated with a low wearing compliance. The change 
of the primary end points of patients who wore class II CS after 
hindfoot and ankle surgery shows no statistical difference in 
comparison to the control group, who wore no CS after the sur-
gery. From other studies, it is known that patients’ statements on 
wearing behavior of orthopedic devices are not reliable,1,7,9,14 
Table 2. Results of All Participants and Comparison of Intervention Group vs Control Group.
Characteristic
All Patients (N = 74) Group I (n = 37)a Group II (Control Group) (n = 39)
Preoperatively, 
Mean (Range)
12 Weeks 
Postoperatively, 
Mean (Range)
P 
Value
Preoperatively, 
Mean (Range)
12 Weeks 
Postoperatively, 
Mean (Range)
P 
Value
Preoperatively, 
Mean (Range)
12 Weeks 
Postoperatively, 
Mean (Range)
P 
Value
Ankle swelling, mm 226 (173-280) 233 (170-310) .312 224 (185-270) 234 (190-285) .337 228 (173-280) 232 (190-310) .221
Pain, VAS (points) 1.2 (0-5) 1.7 (0-7) .045 1 (0-5) 1.7 (0-7) .662 1.4 (0-5) 1.9 (0-7) .212
Quality of life, SF-
36 (points)
37 (5-61) 34 (10-61) .201 38 (15-61) 38 (14-59) .805 35 (5-59) 30 (10-60) .081
AOFAS (points) 71 (12-95) 78 (30-100) .073 68 (34-92) 76 (30-100) .132 74 (12-95) 76 (45-100) .579
Abbreviations: AOFAS, American Orthopaedic Foot & Ankle Score; SF-36 = 36-item Short Form questionnaire; VAS, visual analog scale.
aWearing time h (total compressive stockings wearing time measured in absolute hours during the declared period from postoperative weeks 2-6) = 136 (range, 0-470) 
hours. Wearing time % (compressive stockings wearing time in hours in relation to the declared wearing time of 8 hours per day) = 65% (range, 0-209%).
Figure 4. Boxplots showing the differences of the primary endpoint parameters between the intervention group (with compressive 
stockings) versus the control group (no compressive stockings).
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Figure 5. Boxplots showing the differences of the primary endpoints between patients from group I with high compliance vs patients 
from group II with low compliance.
Table 3. Results of Participants With High vs Low Wearing Compliance.
Characteristic
Participants With High Wearing Compliance (>80%) 
(n = 16)
Participants With Low Wearing Compliance (<80%) 
(n = 21)
Preoperatively, 
Mean (Range)
12 Weeks 
Postoperatively, Mean 
(Range) P Value
Preoperatively, 
Mean (Range)
12 Weeks 
Postoperatively, Mean 
(Range)
P 
Value
Ankle swelling, 
mm
220 (190-260) 6 weeks: 225 (195-270)
12 weeks: 233 (200-265)
.534
.348
227 (185-270) 6 weeks: 242 (190-330)
12 weeks: 233 (190-285)
.381
.357
Pain, VAS 
(points)
0.7 (0-2.5) 1.2 (0-5) .325 1.2 (0-5) 2.2 (0-6) .132
Quality of life SF-
36 (points)
41 (18-61) 42 (17-59) .869 37 (15-56) 34 (14-53) .544
AOFAS (points) 74 (46-90) 80 (36-100) .352 66 (34-92) 73 (30-100) .321
Abbreviations: AOFAS, American Orthopaedic Foot & Ankle Score; SF-36 = 36-item Short Form questionnaire; VAS, visual analog scale.
aWearing time h (total compressive stockings wearing time measured in absolute hours during the declared period from postoperative weeks 2-6) 
= 270 (range, 174-470) hours for high-compliance group and 270 (range, 174-470) hours for low-compliance group. Wearing time % (compressive 
stockings wearing time in hours in relation to the declared wearing time of 8 hours per day) = 129% (range, 84-209%) for high-compliance group and 
16% (range, 0-74%) for low-compliance group.
and the real CS wearing time and also the clinical effect of post-
operative CS are actually unknown. In those studies that 
reported a positive influence of postoperative CS, the CS wear-
ing behavior was not controlled by a sensor.13,15 Our study is 
the first that controlled the patients’ CS wearing compliance 
with a sensor. By knowing the objective patients’ CS wearing 
time, it is more reliable to detect if any outcome differences are 
associated with the postoperative CS therapy or not.
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The average CS wearing time from the 37 patients of the 
intervention group was 136 hours, which correlates to a 
compliance rate of 65%. More than the half of them (57%, 
n = 21) had a compliance rate of only 16% or an average 
absolute wearing time of 34 hours. Only 43% (n = 16) of the 
patients wore the CS for at least 80% of the declared wear-
ing time of 8 hours per day for 4 weeks (224). Surprisingly, 
the changes of scores of these 16 patients who wore the 
stockings properly showed no statistical differences to the 
results of the 21 patients with noncompliance or low com-
pliance or the control group. Therefore, it seems that the 
study hypothesis of the believed positive influence of CS 
after hindfoot or ankle surgery was incorrect.
The reason for the low compliance might be the uncom-
fortable constricting effect of CS, which was especially 
reported from the first participants with forefoot and mid-
foot surgeries. These (total of 4) adverse events led to a 
change in the study plan, and only patients with hindfoot 
and ankle surgery were recruited for the further study. This 
observation leads to the possible assumption that the use of 
grade II CS seems to be contraindicated after forefoot or 
midfoot surgery.
Because of the expected constricting effect of the post-
operative use of CS, each participant was instructed to wear 
the CS in the morning when swelling of the feet is less than 
during the day. In addition, all patients were instructed to 
use an adjustment aid, which was a 100% nylon band to 
help to easily adjust the CS on the operated foot. Most of 
the patients with low compliance claimed they felt discom-
fort while wearing and taking off the CS. One would expect 
higher wearing compliance rates in patients with postopera-
tive cast treatment. Interestingly, the cast rate in the low-
compliance group was 71% (15 of the 21) and 63% (10 of 
the 16 patients) in the high-compliance group. Therefore, 
the adjustment of a postoperative cast did not influence the 
compliance rate in our study.
The study had 3 limitations. First, the power analysis 
recommended 37 participants for each arm to detect statisti-
cal differences. As the subanalysis of the intervention arm 
revealed 16 patients with high compliance and 21 patients 
with low compliance, it is possible that a statistical type II 
error existed due to the lack of power of this subanalysis. 
Therefore, the statement about the CS effect in patients with 
high wearing compliance has to be taken in that context, 
and maybe significant differences would be visible if the 
participant numbers of the subgroup analysis were high 
enough (≥37). Second, the fact that the patients had various 
operative procedures on their hindfoot might cause a prob-
lem of reproducibility of the therapy effect. By the use of a 
control group with the same distribution of operative inter-
ventions, the error should have been reduced. Finally, the 
follow-up period of 12 weeks was relatively short. However, 
as the results were already similar after 12 weeks, it is 
highly possible that no further differences would be seen in 
the future.
Conclusion
This study did not show any significant beneficial effects of 
postoperative CS therapy on subjective or objective out-
come parameters of patients after hindfoot and ankle sur-
gery. Its use after hindfoot surgery was associated with low 
patient compliance. Furthermore, the results of the 16 
patients who wore the stockings with a high compliance 
rate were surprisingly not statistically different compared to 
the results of 21 patients with noncompliance or low 
compliance.
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